XTalks
DECEMBER 20, 2023
Check out this article to learn about the biotech companies that went public this year. The companies include a diverse range engaged in innovative approaches in areas like oncology, genetic medicines, inflammatory diseases, dermatology and cardiorenal therapy.
pharmaphorum
JULY 8, 2022
Pharma companies have begun to explore a host of novel digital endpoints that could have far-reaching implications for accelerating drug development and adoption. That is what’s exciting – as we see DCTs continue to play such a key role that they become the standard for the future of clinical research,” predicts Reites.
The Pharma Data
DECEMBER 17, 2020
Martin Carter Professor in Clinical Investigation and Head of the Laboratory of Investigative Dermatology at The Rockefeller University and Weinblatt is the co-director of Clinical Rheumatology at the Brigham and Women’s Hospital. AB2 Bio – Swiss pharma company AB2 Bio Ltd.
Expert insights. Personalized for you.
59 
Let's personalize your content